Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
An initial report of memory avoidance whole brain radiotherapy to treat brain metastases.
Journal: Neuro-oncology advances
Published: April 05, 2026
Synthetic CT artifacts in MR-only brain radiotherapy: Clinical implementation experience.
Journal: Journal of applied clinical medical physics
Published: March 11, 2026
Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review.
Journal: International journal of molecular sciences
Published: February 05, 2026
Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis.
Journal: Breast cancer research and treatment
Published: January 07, 2026
Early Integrated Neuropsychological Care for Patients with Brain Metastases: A Randomized Controlled Trial (ATHENA Trial).
Journal: International journal of radiation oncology, biology, physics
Published: December 20, 2025
Preoperative Single-Fraction Versus Fractionated Stereotactic Radiation Therapy: A Single-Institutional Analysis of 299 Resected Metastases.
Journal: Advances in radiation oncology
Published: December 09, 2025
Management of intermediate-sized brain metastases of the primary motor cortex.
Journal: Journal of neuro-oncology
Published: November 07, 2025
Nodular Meningeal Recurrence After Laser Interstitial Thermal Therapy for Brain Metastasis: Diagnostic Challenges and Role of Reirradiation With Preoperative Fractionated Stereotactic Radiation Therapy.
Journal: Advances in radiation oncology
Published: November 06, 2025
Improved Progression-Free Survival Following Dose-Escalated Versus Standard-Dose Postoperative Radiation Therapy for High-Risk Meningiomas: An International Multicenter Individual Patient-Level Meta-Analysis (FIRESTORM).
Journal: International journal of radiation oncology, biology, physics
Published: September 25, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.
Journal: Neuro-oncology advances
Published: March 26, 2025
Last Updated: 09/26/2026